Aaron G. Mammoser
Experienced in Epilepsy

Dr. Aaron G. Mammoser

Neurology | Neurosurgery
Piedmont Healthcare
Piedmont Physicians Neuro Oncology Atlanta
2001 Peachtree Road NE, Suite 645, 
Atlanta, GA 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth

Experienced in Epilepsy
Piedmont Healthcare
Piedmont Physicians Neuro Oncology Atlanta
2001 Peachtree Road NE, Suite 645, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Aaron Mammoser is a Neurologist and a Neurosurgery provider in Atlanta, Georgia. Dr. Mammoser is rated as an Experienced provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Mammoser is currently accepting new patients.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
SUNY At Buffalo, Roswell Park Graduate Division, 2000
Residency
University of Michigan, Neurology, 2009
Specialties
Neurology
Neurosurgery
Licenses
Psychiatry & Neurology in MI
Board Certifications
American Board Of Psychiatry And Neurology
Fellowships
University of Texas, MD Anderson Medical Center, Neuro-Oncology, 2011
Hospital Affiliations
Piedmont Newton Hospital
Piedmont Hospital, Inc
Piedmont Fayette Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Piedmont Physicians Neuro Oncology Atlanta
2001 Peachtree Road NE, Suite 645, Atlanta, GA 30309
Call: 404-605-2050

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Enrollment Status: Recruiting
Publish Date: December 12, 2025
Intervention Type: Drug
Study Drugs: Vismodegib, GSK2256098, Capivasertib, Abemaciclib
Study Phase: Phase 2
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Enrollment Status: Recruiting
Publish Date: September 09, 2025
Intervention Type: Drug, Radiation, Biological
Study Drugs: Temozolomide, Lomustine, Regorafenib, Paxalisib, VAL-083
Study Phase: Phase 2/Phase 3
Genomically-Guided Treatment Trial in Brain Metastases
Genomically-Guided Treatment Trial in Brain Metastases
Enrollment Status: Suspended
Publish Date: December 12, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Paxalisib, Entrectinib
Study Phase: Phase 2
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Enrollment Status: Completed
Publish Date: August 22, 2025
Intervention Type: Drug
Study Drug: Ramipril
Study Phase: Phase 2
Standard Chemotherapy Versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients With Recurrent Glioblastoma Multiforme (GBM).
Standard Chemotherapy Versus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients With Recurrent Glioblastoma Multiforme (GBM).
Enrollment Status: Completed
Publish Date: April 15, 2025
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 3
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: August 02, 2024
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

17 Total Publications

CRE25-043: Treatment of HER2-Positive Breast Cancer With Leptomeningeal Metastases With Intrathecal Trastuzumab.
CRE25-043: Treatment of HER2-Positive Breast Cancer With Leptomeningeal Metastases With Intrathecal Trastuzumab.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
View All 17 Publications
Similar Doctors
David A. Olson
Distinguished in Epilepsy
Dr. David A. Olson
Neurology
Distinguished in Epilepsy
Dr. David A. Olson
Neurology

DeKalb Neurology Group

2665 North Decatur Road, Ste540, 
Decatur, GA 
 (6.5 miles away)
404-508-4008
Experience:
37+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Olson is a Neurologist in Decatur, Georgia. Dr. Olson has been practicing medicine for over 37 years and is rated as a Distinguished provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Epilepsy, Memory Loss, Lewy Body Dementia (LBD), and Peripheral Neuropathy.

Distinguished in Epilepsy
Dr. Ezequiel L. Gleichgerrcht
Neurology
Distinguished in Epilepsy
Dr. Ezequiel L. Gleichgerrcht
Neurology

Emory Brain Health Center

12 Executive Park Drive Northeast, 
Atlanta, GA 
 (4.3 miles away)
404-778-3444
Experience:
13+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ezequiel Gleichgerrcht is a Neurologist in Atlanta, Georgia. Dr. Gleichgerrcht has been practicing medicine for over 13 years and is rated as an Advanced provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Epilepsy, Seizures, Generalized Tonic-Clonic Seizure, and Frontotemporal Dementia.

Distinguished in Epilepsy
Dr. Nigel Pedersen
Neurology
Distinguished in Epilepsy
Dr. Nigel Pedersen
Neurology

Emory Pain Center-Executive Park

12 Executive Park Dr NE, 
Atlanta, GA 
 (3.5 miles away)
404-778-3444
Languages Spoken:
English
See accepted insurances

Nigel Pedersen is a Neurologist in Atlanta, Georgia. Dr. Pedersen is rated as an Advanced provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Epilepsy, Seizures, Generalized Tonic-Clonic Seizure, Deep Brain Stimulation, and Awake Craniotomy.

VIEW MORE EPILEPSY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mammoser's expertise for a condition
ConditionClose
    • Distinguished
    • Astrocytoma
      Dr. Mammoser is
      Distinguished
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Mammoser is
      Distinguished
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    • Brain Tumor
      Dr. Mammoser is
      Distinguished
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Mammoser is
      Distinguished
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Ependymoma
      Dr. Mammoser is
      Distinguished
      . Learn about Ependymoma.
      See more Ependymoma experts
    • Glioblastoma
      Dr. Mammoser is
      Distinguished
      . Learn about Glioblastoma.
      See more Glioblastoma experts
    View All 14 Distinguished Conditions
    • Advanced
    • Brain Herniation
      Dr. Mammoser is
      Advanced
      . Learn about Brain Herniation.
      See more Brain Herniation experts
    • Brain Stem Cancer
      Dr. Mammoser is
      Advanced
      . Learn about Brain Stem Cancer.
      See more Brain Stem Cancer experts
    • Choroid Plexus Papilloma
      Dr. Mammoser is
      Advanced
      . Learn about Choroid Plexus Papilloma.
      See more Choroid Plexus Papilloma experts
    • Diffuse Midline Glioma H3 K27M-Mutant
      Dr. Mammoser is
      Advanced
      . Learn about Diffuse Midline Glioma H3 K27M-Mutant.
      See more Diffuse Midline Glioma H3 K27M-Mutant experts
    • Dysembryoplastic Neuroepithelial Tumors (DNET)
      Dr. Mammoser is
      Advanced
      . Learn about Dysembryoplastic Neuroepithelial Tumors (DNET).
      See more Dysembryoplastic Neuroepithelial Tumors (DNET) experts
    • Gliomatosis Cerebri
      Dr. Mammoser is
      Advanced
      . Learn about Gliomatosis Cerebri.
      See more Gliomatosis Cerebri experts
    View All 10 Advanced Conditions
    • Experienced
    • Alien Hand Syndrome
      Dr. Mammoser is
      Experienced
      . Learn about Alien Hand Syndrome.
      See more Alien Hand Syndrome experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Mammoser is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Autosomal Dominant Partial Epilepsy with Auditory Features
      Dr. Mammoser is
      Experienced
      . Learn about Autosomal Dominant Partial Epilepsy with Auditory Features.
      See more Autosomal Dominant Partial Epilepsy with Auditory Features experts
    • CAPOS Syndrome
      Dr. Mammoser is
      Experienced
      . Learn about CAPOS Syndrome.
      See more CAPOS Syndrome experts
    • Cerebellum Agenesis Hydrocephaly
      Dr. Mammoser is
      Experienced
      . Learn about Cerebellum Agenesis Hydrocephaly.
      See more Cerebellum Agenesis Hydrocephaly experts
    • Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
      Dr. Mammoser is
      Experienced
      . Learn about Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
      See more Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy experts
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.